Type II collagen derived fragment (COLL2-1) is new marker predictive of osteoarthritis progressionHenrotin, Yves ; ; et alin Osteoporosis International (2002, November), 13(Suppl.3), 17 Detailed reference viewed: 11 (0 ULg) Contribution of whole-body (18)FDG PET imaging in the management of cervical cancer; Thille, Alain ; Fridman, Viviana et alin Gynecologic Oncology (2002), 87(1), 90-97 OBJECTIVE: The objective of this study was to assess the contribution of [(18)F]fluoro-2-deoxy-D-glucose positron emission tomography ((18)FDG PET) imaging in the management of cervical cancer. METHODS ... [more ▼] OBJECTIVE: The objective of this study was to assess the contribution of [(18)F]fluoro-2-deoxy-D-glucose positron emission tomography ((18)FDG PET) imaging in the management of cervical cancer. METHODS: Fully corrected whole-body PET was performed in 60 patients (pts) with proven cervical cancer. In pretreatment staging, 22 pts underwent PET in addition to routine protocol including International Federation of Obstetrics and Gynecology (FIGO) staging and pelvic magnetic resonance imaging (MRI). Eighteen of them had pelvic lymphadenectomy. After treatment, PET was performed in 38 pts routinely followed up by clinical and radiological examinations. Results of PET and routine protocols were compared to final diagnoses, including histological findings in 31 pts and clinical outcomes in the other cases. Median follow-up time was 12 +/- 7.3 months. RESULTS: In all but 2 patients (FIGO stage IA), both PET and MRI detected the primary tumor. In 6 pts, MRI alone noted loco-regional tumor spread but PET localized 9 unsuspected extrapelvic nodal sites (6 para-aortic, 2 mediastinal, and 1 supra-clavicular). However, PET missed 8 microscopic pelvic nodal metastases. In 18% of the patients, PET staging significantly influenced the treatment choices. In follow-up, PET accurately diagnosed a recurrent disease in 13 pts with falsely negative or equivocal conventional imaging (CI). Ten patients with a negative PET were still in complete remission after a minimal follow-up time of 12 months. Overall, the agreement of PET with final diagnosis was significantly better than that of routine protocol (P < 0.05). CONCLUSIONS: Whole-body (18)FDG PET appears useful in the management of cervical cancer, in particular for staging extrapelvic metastases or optimally detecting a recurrence. MRI is better indicated for evaluating the loco-regional status of the disease. [less ▲] Detailed reference viewed: 15 (1 ULg) Subchondral tibial bone mineral density predicts joint space narrowing at the medial femoro-tibial compartment in patients with knee osteoarthritisBruyère, Olivier ; LAMBERT, Virginie ; et alin Arthritis and Rheumatism (2002, September), 16(number 9 (suppl.)), 154 Detailed reference viewed: 5 (0 ULg) Clinical severity of knee osteoarthritis poorly predicts long-term radiographic outcomesBruyère, Olivier ; Ethgen, Olivier ; Lejeune, Eric et alin Arthritis and Rheumatism (2002, September), 46(number 9 (suppl.)), 153 Detailed reference viewed: 8 (5 ULg) Correlation between biochemical markers of bone and cartilage metabolism and structural progression of hand osteoarthritis. A three year prospective studyBruyère, Olivier ; COLLETTE, Julien ; Lejeune, Eric et alin Arthritis and Rheumatism (2002, September), 46(number 9 (suppl.)), 152-3 Detailed reference viewed: 2 (0 ULg) Baseline measurement of urine pyridinoline and deoxypyridinoline is correlated with 3-year hip osteoarthritis progressionBruyère, Olivier ; COLLETTE, Julien ; Lejeune, Eric et alin Arthritis and Rheumatism (2002, September), 46(number 9 (suppl.)), 149 Detailed reference viewed: 5 (1 ULg) In Vitro Susceptibility Testing of Aspergillus fumigatus against Posaconazole: Comparison of NCCLS M38-P and E-Test MethodsHayette, Marie-Pierre ; ; Seidel, Laurence et alPoster (2002, September) Posaconazole is a second-generation triazole and structural analogue of itraconazole. This drug has fungicidal activity against yeasts and filamentous fungi. The aim of our study was to evaluate E-test ... [more ▼] Posaconazole is a second-generation triazole and structural analogue of itraconazole. This drug has fungicidal activity against yeasts and filamentous fungi. The aim of our study was to evaluate E-test method for in vitro susceptibility testing of Aspergillus fumigatus isolates against posaconazole. METHODS: A total of 121 isolates of A. fumigatus were selected as follows: 106 clinical strains from colonized patients, 18 from patients with invasive aspergillosis and 7 environmental isolates. Their in vitro susceptibility was evaluated by E-test (Abbiodisk, Sweden) and compared with NCCLS microdilution reference method (M38-P). Both tests were performed with RPMI 1640 medium at 35 degrees C. MIC values were read after 24h (MIC-24h) and 48h (MIC-48h) incubation time by E-test method. Two MIC endpoints were determined by NCCLS method: 1.no visible reduction of growth (MIC-0); 2. 50% reduction (or more) of growth (MIC-2). Three A. fumigatus reference strains (IHEM 5734, 6149 and 13935) were included as control. RESULTS: Geometric mean MICs (microg/ml) were respectively 0.02 for E-test at 24h and 0.029 at 48h. MIC-0 and MIC-2 values were respectively 0.19 and 0.018 microg/ml. One correlation between both methods was observed for MICs-24h and MICs-2s (p<.05). However, there was no significant difference according to origin of isolates (p<.05). CONCLUSIONS: 1. This study assessed the potent role of posaconazole against A. fumigatus isolates with very low MICs. 2. MIC values were not predictive of pathogenicity. 3. E-test method by reading after 24h-incubation time could easily replace the time-consuming NCCLS M38-P reference method. [less ▲] Detailed reference viewed: 17 (0 ULg) Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis; ; Hustinx, Roland et alin Clinical Cancer Research : An Official Journal of the American Association for Cancer Research (2002), 8(9), 2766-2774 Purpose: Many anticancer therapies exert their therapeutic effect by inducing apoptosis in target tumors. We evaluated in a Phase I study the safety and the feasibility of Tc-99m-Annexin V for imaging ... [more ▼] Purpose: Many anticancer therapies exert their therapeutic effect by inducing apoptosis in target tumors. We evaluated in a Phase I study the safety and the feasibility of Tc-99m-Annexin V for imaging chemotherapy-induced apoptosis in human cancers immediately after the first course of chemotherapy. Experimental Design: Fifteen patients presenting with lung cancer (n = 10), lymphoma (n = 3), or breast cancer (n = 2) underwent Tc-99m-Annexin V scintigraphy before and within 3 days after their first course of chemotherapy. Tumor response was evaluated by computed tomography and F-18-fluoro-2-deoxy-D-glucose positron emission tomography scans, 3 months in average after completing the treatment. Median follow-up was 117 days. Results: In all cases, no tracer uptake was observed before treatment. However, 24-48 h after the first course of chemotherapy, 7 patients who showed Tc-99m-Annexin V uptake at tumor sites, suggesting apoptosis, had a complete (n = 4) or a partial response In = 3). Conversely, 6 of the 8 patients who showed no significant posttreatment tumor uptake had a progressive disease. Despite the lack of tracer uptake after treatment, the 2 patients with breast cancer had a partial response. Overall survival and progression-free survival were significantly related to tracer uptake in treated lung cancers and lymphomas (P < 0.05). No serious adverse events were observed. Conclusions: Our preliminary results demonstrated the feasibility and the safety of Tc-99m-Annexin V for imaging apoptosis in human tumors after the first course of chemotherapy. Initial data suggest that early Tc-99m-Annexin V tumor uptake may be a predictor of response to treatment in-patients with late stage lung cancer and lymphoma. [less ▲] Detailed reference viewed: 43 (5 ULg) Increased TGFβ1 plasma level in patients with lung cancer: potential mechanismsBarthelemy, Nicole ; David, Jean-Louis ; Bosquee, Léon et alin European Journal of Clinical Investigation (2002), 32(3), 193-198 Background Plasma transforming growth factor β1 (TGFβ1) levels are elevated in patients with lung cancer. As TGFβ1 is mainly found in platelets and as nonmalignant pulmonary diseases (NMPD) are frequently ... [more ▼] Background Plasma transforming growth factor β1 (TGFβ1) levels are elevated in patients with lung cancer. As TGFβ1 is mainly found in platelets and as nonmalignant pulmonary diseases (NMPD) are frequently associated with lung cancer, we investigated the potential contribution of platelet degranulation and/or of a concomitant NMPD to the increased plasma levels of TGFβ1 reported in patients with lung cancer. Materials and Methods Blood samples were collected in duplicate from 30 healthy subjects, 14 patients suffering from NMPD and 37 patients with lung cancer. The platelet count was determined and the samples were processed to obtain plasma. One sample was collected in EDTA (EDTA plasma) and the other in a mixture inhibiting platelet degranulation (PIM plasma). TGFβ1 concentrations and β-thromboglobulin (βTG) levels, an index of platelet degranulation, were measured in both plasma samples. Results TGFβ1 and βTG plasma levels measured in PIM plasma were lower than those obtained in EDTA plasma. With respect to PIM plasma, both TGFβ1 and βTG levels were higher in patients with lung cancer than those with NMPD and in healthy individuals. In patients with NMPD, only TGFβ1 levels were increased as compared to healthy controls, βTG levels being similar. Conclusion Methods for collecting and processing blood samples are critical in determining reliable circulating TGFβ1 levels. Increased TGFβ1 plasma levels observed in patients with lung cancer are related, at least partly, to concomitant NMPD and also to platelet degranulation as proved by increased βTG levels. [less ▲] Detailed reference viewed: 24 (2 ULg) Influence of daily regimen calcium and vitamin D supplementation on parathyroid hormone secretionReginster, Jean-Yves ; Zegels, Brigitte ; Lejeune, Emmanuelle et alin Calcified Tissue International (2002), 70(2), 78-82 Calcium and vitamin D supplementation has been shown to reduce secondary hyperparathyroidism and play a role in the management of senile osteoporosis. In order to define the optimal regimen of calcium and ... [more ▼] Calcium and vitamin D supplementation has been shown to reduce secondary hyperparathyroidism and play a role in the management of senile osteoporosis. In order to define the optimal regimen of calcium and vitamin D supplementation to produce the maximal inhibition of parathyroid hormone secretion, we have compared the administration of a similar amount of Ca and vitamin D, either as a single morning dose or split in two doses, taken 6 hours apart. Twelve healthy volunteers were assigned to three investigational procedures, at weekly intervals. After a blank control procedure, when they were not exposed to any drug intake, they received two calcium-vitamin D supplement regimens including either two doses of Orocal D3 (500 mg Ca and 400 IU vitamin D) 6 hours apart or one water-soluble effervescent powder pack of Cacit D3 in a single morning dose (1000 mg Ca and 880 IU vitamin D). During the three procedures (control and the two calcium-vitamin D supplementations), venous blood was drawn every 60 minutes for up to 9 hours, for serum Ca and serum PTH measurements. The order of administration of the two Ca and vitamin D supplementation sequences was allocated by randomization. No significant changes in serum Ca were observed during the study. During the 6 hours following Ca and vitamin D supplementation, a statistically significant decrease in serum PTH was observed with both regimens, compared with baseline and with the control procedure. Over this period of time, no differences were observed between the two treatment regimens. However, between the sixth and the ninth hour, serum PTH levels were still significantly decreased compared with baseline with split dose Orocal D3 administration, while they returned to baseline value with the Cacit D3 preparation. During this period, the percentage decrease in serum PTH compared with baseline was significantly more pronounced with Orocal D3 than with Cacit D3 (P = 0.0021). We therefore conclude that the administration of two doses of 500 mg of calcium and 400 IU of vitamin D3 6 hours apart provides a more prolonged decrease in serum PTH levels than the administration of the same total amount of Ca and vitamin D as a single morning dose in young healthy volunteers. This might have implications in terms of protection of the skeleton against secondary hyperparathyroidism and increased bone resorption and turnover in elderly subjects. [less ▲] Detailed reference viewed: 50 (13 ULg) Radiologic features poorly predict clinical outcomes in knee osteoarthritis.Bruyère, Olivier ; ; et alin Scandinavian Journal of Rheumatology (2002), 31(1), 13-6 OBJECTIVES: To assess the impact of radiographic severity and progression on pain and disability. METHODS: Measurements of mean joint space width (JSW), narrowest join space (NJS) point and assessment of ... [more ▼] OBJECTIVES: To assess the impact of radiographic severity and progression on pain and disability. METHODS: Measurements of mean joint space width (JSW), narrowest join space (NJS) point and assessment of symptoms by the WOMAC questionnaire were performed at baseline and after three years in 212 subjects over 50 years with primary knee OA. RESULTS: At baseline, JSW and NJS were not significantly correlated with the scores recorded for the WOMAC global index or its pain, stiffness or function subscales. A statistically significant correlation was observed between the joint space narrowing over three years and the changes observed in the pain subscale of the WOMAC during the same period. The three-year changes in the global WOMAC index in patients within the lowest and the highest quartiles of mean joint space width at baseline showed, in both cases, a statistically (p<0.05) significant favorable difference between patients treated with glucosamine sulphate and those having received placebo. CONCLUSION: Radiographic and clinical progressions of the disease are significantly associated but the clinical relevance of the association is questionable. [less ▲] Detailed reference viewed: 32 (6 ULg) Comparative In Vitro Activity of Amphotericine B, Itraconazole, Voriconazole and Posaconazole against Aspergillus fumigatusHayette, Marie-Pierre ; ; Seidel, Laurence et alPoster (2001, December) Background. New azoles have been successfully used as treatment of invasive aspergillosis. The purpose of this study was to compare the in vitro activity of posaconazole (Posa) with that of amphotericin B ... [more ▼] Background. New azoles have been successfully used as treatment of invasive aspergillosis. The purpose of this study was to compare the in vitro activity of posaconazole (Posa) with that of amphotericin B (AmB), itraconazole (Itra) and voriconazole (Vor) against A. fumigatus isolates according to NCCLS method (M38-P), and to compare visual and spectrophotometric readings for MIC determination. Methods. A total of 106 A. fumigatus isolates were selected as follows: 88 clinical isolates from colonized patients, 18 from patients with invasive aspergillosis and 7 environmental isolates. Their in vitro susceptibility was evaluated by the NCCLS microdilution method (M38-P) in RPMI 1640 medium. Determination of results was made by visual and spectrophotometric readings (630 nm) after 48 hours incubation at 35 degreesC. Three A. fumigatus reference strains (IHEM 5734, 6149 and 13935) were included as control. Results. 1. Geometric mean MICs/MIC90 (microg/ml) obtained by visual reading were respectively 0.66/1 (AmB), 0.37/0.5 (Itra), 0.27/0.5 (Vor) and 0.02/0.03 (Posa). 2. MIC values were comparable by spectrophotometric and by visual readings for all antifungal agents tested (p>.05) and did not depend on the isolates origin (p>.05). 3. Posaconazole had the lowest MICs (p< 0.001). 4. The itraconazole-resistant reference strain did not give cross resistance with voriconazole and posaconazole. CONCLUSIONS: Among azoles, posaconazole had a better in vitro activity against A. fumigatus than did voriconazole or itraconazole. Spectrophotometric reading could replace the less standardized visual reading for NCCLS microdilution method and MIC values obtained were comparable among all A. fumigatus isolates. [less ▲] Detailed reference viewed: 40 (0 ULg) Radiologic features poorly predict clinical outcomes in knee osteoarthritisReginster, Jean-Yves ; Bruyère, Olivier ; et alin Osteoarthritis and Cartilage (2001), 9(Suppl.B), 49 Detailed reference viewed: 8 (4 ULg) Early (3-month) changes in serum osteocalcin and urinary C-telopeptide of type I collagen could be of interest to identify postmenopausal osteoporotic women with the highest risk to present new vertebral deformitiesBruyère, Olivier ; COLLETTE, Julien ; et alin Arthritis and Rheumatism (2001), 44(Suppl.1), 257 Detailed reference viewed: 7 (0 ULg) Short term (1-year) changes in keratan sulfate levels predict long-term (3-year) radiological evolution of knee osteoarthritis in patients treated with glucosamine sulfateReginster, Jean-Yves ; COLLETTE, Julien ; Bruyère, Olivier et alin Arthritis and Rheumatism (2001), 44(Suppl.1), 139 Detailed reference viewed: 5 (0 ULg) Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritisBruyère, Olivier ; Henrotin, Yves ; et alin Arthritis and Rheumatism (2001), 44(Suppl.1), 139 Detailed reference viewed: 3 (0 ULg) Impact of joint space width measurement method on sample size calculation in knee osteoarthritis studiesBruyère, Olivier ; Henrotin, Yves ; et alin Clinical Rheumatology (2001), 5(Suppl.1), 413 Detailed reference viewed: 6 (0 ULg) Radiographic severity of knee osteoarthrits is highly correlated with future progression of the diseaseBruyère, Olivier ; Ethgen, Olivier ; et alin Clinical Rheumatology (2001), 5(Suppl.1), 412 Detailed reference viewed: 2 (0 ULg) Radiologic features poorly predict clinical outcomes in knee osteoarthritisReginster, Jean-Yves ; Bruyère, Olivier ; et alin Clinical Rheumatology (2001), 5(Suppl.1), 412 Detailed reference viewed: 5 (0 ULg) Tibial subchondral sclerosis is significantly correlated with long-term (3-year) radiological progression of knee osteoarthritisBruyère, Olivier ; Henrotin, Yves ; et alin Clinical Rheumatology (2001), 5(Suppl.1), 412 Detailed reference viewed: 4 (1 ULg) |
||